Text Size

Expectations, Satisfaction and Quality of Life in Total Hip Arthroplasty

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Hospital for Special Surgery, New York
ClinicalTrials.gov Identifier:
NCT00197990
First received: September 12, 2005
Last updated: November 22, 2011
Last verified: November 2011
History of Changes
  Purpose

The goals of this study are to identify predictors of improvement in quality of life and satisfaction with total hip arthroplasty three to five years after surgery.


Condition
Hip Osteoarthritis
Arthroplasty, Replacement, Hip

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Expectations, Satisfaction and Quality of Life in Total Hip Arthroplasty

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Hospital for Special Surgery, New York:

Primary Outcome Measures:
  • Fulfillment of expectations [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Satisfaction with THA [ Designated as safety issue: No ]

Enrollment: 405
Study Start Date: July 2003
Study Completion Date: June 2004
Primary Completion Date: June 2004 (Final data collection date for primary outcome measure)
Detailed Description:

The goals of this study are to identify predictors of improvement in quality of life and satisfaction with total hip arthroplasty three to five years after surgery. Predictors that will be considered are variables that were obtained prospectively and systematically at the time of surgery, including demographic characteristics, functional status, expectations, perioperative complications, and comorbidity. At the follow-up functional status and patient satisfaction will be measured, as well as fulfillment of expectations and predispositional factors.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients who had total hip arthroplasty

Criteria

Inclusion Criteria:

  • Patients will be eligible for this study if they are part of an assembled cohort of patients who underwent primary unilateral or bilateral total hip arthroplasty in 1998-2000 at the Hospital for Special Surgery.

Exclusion Criteria:

  • Patients will be excluded if they are unable to be interviewed, refuse to participate, or are deceased.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00197990

Locations
United States, New York
Hospital for Special Surgery
New York, New York, United States, 10021
Sponsors and Collaborators
Hospital for Special Surgery, New York
Investigators
Principal Investigator: Carol A Mancuso, MD Hospital for Special Surgery, New York
  More Information

Publications:

Responsible Party: Hospital for Special Surgery, New York
ClinicalTrials.gov Identifier: NCT00197990     History of Changes
Other Study ID Numbers: 22078, Arthritis Foundation-NY Chapt
Study First Received: September 12, 2005
Last Updated: November 22, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by Hospital for Special Surgery, New York:
total hip arthroplasty
expectations
satisfaction
quality of life

Additional relevant MeSH terms:
Osteoarthritis
Osteoarthritis, Hip
Arthritis
 Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases

ClinicalTrials.gov processed this record on October 16, 2012